NCT04160715Recruiting
Korean Idiopathic Pulmonary Fibrosis Registry
Source: ClinicalTrials.gov · Last updated 13 Nov 2019 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 30 Oct 2019
- Start date
- Jan 2016
- Primary completion date
- Jan 2025
- Lead sponsor
- Seoul National University Hospital
- Diseases
- Idiopathic pulmonary fibrosis
- NCT number
- NCT04160715
What you commit to
- Study type: Observational
- Planned participants: 3000
- From Jan 2016 to the primary completion date, Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other interstitial lung diseases except for IPF
- connective tissue disease-related ILD
Other
- exposure-related ILD
Who the study is looking for
- IPF patients diagnosed by multidisciplinary discussion
Age in the registry: 30 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul National University Bundang Hospital Coordinator of this site? Confirm its status | Seongnam-si | South Korea | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.